Similar Papers

Paper Title
Journal
Date
Author
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
Journal of Hepatology | VOL. 55
01 Mar 2011
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
Pratima Sharma ... Anna S Lok
Gastroenterology | VOL. 141
Pratima Sharma, et. al.Pratima Sharma ... Anna S Lok
25 Oct 2011
Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response
Peter Ferenci ... Petra Steindl–Munda
Gastroenterology | VOL. 135
Peter Ferenci, et. al.Peter Ferenci ... Petra Steindl–Munda
17 Apr 2008
Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C
Michael Von Wagner ... Stefan Zeuzem
Gastroenterology | VOL. 129
Michael Von Wagner, et. al.Michael Von Wagner ... Stefan Zeuzem
01 Aug 2005
View more papers

More From: Journal of Gastroenterology and Hepatology

Paper Title
Journal
Date
Author
Thyromimetics and MASLD: Unveiling the Novel Molecules Beyond Resmetirom.
Devaraj Ezhilarasan
Journal of gastroenterology and hepatology | VOL. -
Devaraj EzhilarasanDevaraj Ezhilarasan
16 Jan 2025
Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle- and High-Income Countries: A Systematic Review.
Yuxuan Li ... Guihua Zhuang
Journal of gastroenterology and hepatology | VOL. -
Yuxuan Li, et. al.Yuxuan Li ... Guihua Zhuang
16 Jan 2025
Efficacy of Magnifying Texture and Color Enhancement Imaging With Indigo Carmine as an Alternative to Crystal Violet for Colorectal Tumors.
Tsubasa Ishikawa ... Naoya Kato
Journal of gastroenterology and hepatology | VOL. -
Tsubasa Ishikawa, et. al.Tsubasa Ishikawa ... Naoya Kato
14 Jan 2025
Clonorchis sinensis Promotes Intrahepatic Cholangiocarcinoma Progression by Activating FASN-Mediated Fatty Acid Metabolism.
Xiaoxue Ren ... Ying Zhang
Journal of gastroenterology and hepatology | VOL. -
Xiaoxue Ren, et. al.Xiaoxue Ren ... Ying Zhang
13 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.